EQT Consents to Sell Its Stake in Galderma Group AG to L'Oréal S.A.
Share Sale Announcement: EQT VIII has signed an agreement to sell approximately 24 million shares of Galderma Group AG to L'Oréal S.A. at an undisclosed premium, with around 6 million shares attributable to EQT.
Regulatory Approval: The completion of the share sale is contingent upon receiving customary regulatory approvals.
Securities Disclaimer: The press release clarifies that it does not constitute an offer to sell or solicit offers to buy Galderma Group AG securities, nor does it serve as a prospectus under Swiss law.
U.S. Securities Regulations: The announcement emphasizes that the securities cannot be offered or sold in the United States without proper registration or exemption, and there will be no public offering in the U.S.
About the author









